TENTATIVE DESIGNATED RESPONSE FOR SYPHILIS SEROLOGY PROGRAM |
| |
TRIAL 01-17-4 |
Control material NO. | 01-17-4-1 | 01-17-4-2 | 01-17-4-3 | 01-17-4-4 | Non treponemal test | Non-Reactive | Non-Reactive | Reactive | Reactive | Treponemal test | NS | NS | Reactive | Reactive |
|
| |
|
TENTATIVE DESIGNATED RESPONSE FOR HEPATITIS B VIRUS
SEROLOGY PROGRAM |
TRIAL 02-17-4 |
| |
Control material NO. | 02-17-4-1 | 02-17-4-2 | 02-17-4-3 | 02-17-4-4 | HBsAg | NEGATIVE
0.58± 0.11(ECLIA) | NEGATIVE
0.56± 0.11(ECLIA) | POSITIVE
1,519.55± 134.58
(ECLIA) | POSITIVE
2,997.86±236.37(ECLIA) | antiHBs
(all methods)
(mIU/ml) | POSITIVE
318.27 ±81.58 | POSITIVE
255.13 ± 53.42 | NEGATIVE
0.69± 1.02 | NEGATIVE
0.60±0.85 | antiHBc | POSITIVE | POSITIVE | POSITIVE | POSITIVE | HBeAg | NEGATIVE | NEGATIVE | NEGATIVE | NEGATIVE | antiHBe | POSITIVE | POSITIVE | POSITIVE | POSITIVE |
|
| |
| |
TENTATIVE DESIGNATED RESPONSE FOR SYPHILIS SEROLOGY PROGRAM |
| |
TRIAL 01-17-3 |
Control material NO. | 01-17-3-1 | 01-17-3-2 | 01-17-3-3 | 01-17-3-4 | Non treponemal test | Reactive | Reactive | Reactive | Reactive | Treponemal test | Reactive | Reactive | Reactive | Reactive |
|
| |
| |
TENTATIVE DESIGNATED RESPONSE FOR HEPATITIS B VIRUS
SEROLOGY PROGRAM |
TRIAL 02-17-3 |
| |
Control material NO. | 02-17-3-1 | 02-17-3-2 | 02-17-3-3 | 02-17-3-4 | HBsAg | NEGATIVE
0.59± 0.13(ECLIA) | NEGATIVE
0.56± 0.12(ECLIA) | POSITIVE
7,877.87± 599.28
(ECLIA) | POSITIVE
9,764.01±686.08(ECLIA) | antiHBs
(all methods)
(mIU/ml) | POSITIVE
599.69 ±155.04 | POSITIVE
122.74 ± 40.03 | NEGATIVE
0.58± 0.96 | NEGATIVE
0.44±0.70 | antiHBc | NEGATIVE | POSITIVE | POSITIVE | POSITIVE | HBeAg | NEGATIVE | NEGATIVE | NEGATIVE | NEGATIVE | antiHBe | NEGATIVE | POSITIVE | POSITIVE | POSITIVE |
|
| |
| |
TENTATIVE DESIGNATED RESPONSE FOR SYPHILIS SEROLOGY PROGRAM |
